Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joyce Doorn

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Clinical Chemistry and Laboratory Medicine|January 2, 2026
At-home blood collection for clinical chemistry analyses in a kidney transplant population: a feasibility studyJorrit Hoekstra, Manon Wilpshaar, Stefan Berger, et al.
Tissue Engineering. Part A|September 28, 2011
Forskolin enhances in vivo bone formation by human mesenchymal stromal cellsJoyce Doorn, Ramakrishnaiah Siddappa, Clemens A van Blitterswijk, et al.
Tissue Engineering. Part B, Reviews|October 15, 2011
Therapeutic applications of mesenchymal stromal cells: paracrine effects and potential improvementsJoyce Doorn, Guido Moll, Katarina Le Blanc, et al.
Journal of Tissue Engineering and Regenerative Medicine|December 25, 2009
Timing, rather than the concentration of cyclic AMP, correlates to osteogenic differentiation of human mesenchymal stem cellsRamakrishnaiah Siddappa, Joyce Doorn, Jun Liu, et al.
Tissue Engineering. Part A|March 28, 2013
Insulin-like growth factor-I enhances proliferation and differentiation of human mesenchymal stromal cells in vitroJoyce Doorn, Scott J Roberts, Janneke Hilderink, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 26, 2009
ALK2 R206H mutation linked to fibrodysplasia ossificans progressiva confers constitutive activity to the BMP type I receptor and sensitizes mesenchymal cells to BMP-induced osteoblast differentiation and bone formationMaarten van Dinther, Nils Visser, David J J de Gorter, et al.
Biomaterials|May 31, 2011
Pro-osteogenic trophic effects by PKA activation in human mesenchymal stromal cellsJoyce Doorn, Jeroen van de Peppel, Johannes P T M van Leeuwen, et al.
Tissue Engineering. Part A|June 1, 2012
Diverse effects of cyclic AMP variants on osteogenic and adipogenic differentiation of human mesenchymal stromal cellsJoyce Doorn, Maarten Leusink, Nathalie Groen, et al.
Frontiers in Neurology|October 11, 2021
Kidney Function in Patients With Neuromuscular Disease: Creatinine Versus Cystatin CElles M Screever, Jenny E Kootstra-Ros, Joyce Doorn, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 21, 2008
cAMP/PKA pathway activation in human mesenchymal stem cells in vitro results in robust bone formation in vivoRamakrishnaiah Siddappa, Anton Martens, Joyce Doorn, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Clinical Chemistry and Laboratory Medicine|January 2, 2026
At-home blood collection for clinical chemistry analyses in a kidney transplant population: a feasibility studyJorrit Hoekstra, Manon Wilpshaar, Stefan Berger, et al.
Tissue Engineering. Part A|September 28, 2011
Forskolin enhances in vivo bone formation by human mesenchymal stromal cellsJoyce Doorn, Ramakrishnaiah Siddappa, Clemens A van Blitterswijk, et al.
Tissue Engineering. Part B, Reviews|October 15, 2011
Therapeutic applications of mesenchymal stromal cells: paracrine effects and potential improvementsJoyce Doorn, Guido Moll, Katarina Le Blanc, et al.
Journal of Tissue Engineering and Regenerative Medicine|December 25, 2009
Timing, rather than the concentration of cyclic AMP, correlates to osteogenic differentiation of human mesenchymal stem cellsRamakrishnaiah Siddappa, Joyce Doorn, Jun Liu, et al.
Tissue Engineering. Part A|March 28, 2013
Insulin-like growth factor-I enhances proliferation and differentiation of human mesenchymal stromal cells in vitroJoyce Doorn, Scott J Roberts, Janneke Hilderink, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 26, 2009
ALK2 R206H mutation linked to fibrodysplasia ossificans progressiva confers constitutive activity to the BMP type I receptor and sensitizes mesenchymal cells to BMP-induced osteoblast differentiation and bone formationMaarten van Dinther, Nils Visser, David J J de Gorter, et al.
Biomaterials|May 31, 2011
Pro-osteogenic trophic effects by PKA activation in human mesenchymal stromal cellsJoyce Doorn, Jeroen van de Peppel, Johannes P T M van Leeuwen, et al.
Tissue Engineering. Part A|June 1, 2012
Diverse effects of cyclic AMP variants on osteogenic and adipogenic differentiation of human mesenchymal stromal cellsJoyce Doorn, Maarten Leusink, Nathalie Groen, et al.
Frontiers in Neurology|October 11, 2021
Kidney Function in Patients With Neuromuscular Disease: Creatinine Versus Cystatin CElles M Screever, Jenny E Kootstra-Ros, Joyce Doorn, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 21, 2008
cAMP/PKA pathway activation in human mesenchymal stem cells in vitro results in robust bone formation in vivoRamakrishnaiah Siddappa, Anton Martens, Joyce Doorn, et al.
Pageof 2